Status:
COMPLETED
Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J
Lead Sponsor:
National Institutes of Health Clinical Center (CC)
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Leukemia
Lymphoma
Eligibility:
All Genders
2-21 years
Brief Summary
RATIONALE: Studying bone marrow and blood samples from patients with leukemia or lymphoma treated with arsenic trioxide may help doctors learn more about cancer. PURPOSE: This research study is asses...
Detailed Description
OBJECTIVES: * To assess the pharmacokinetic and pharmacodynamic profiles of arsenic trioxide in pediatric patients treated on protocol NCI-00-C-0070J. OUTLINE: Bone marrow or peripheral blood mononu...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Histologically confirmed leukemia or lymphoma refractory to standard curative treatment regimens
- No meningeal leukemia or lymphoma
- No HIV-related lymphoma
- No lymphoproliferative diseases
- Received treatment on protocol NCI-00-C-0070J
- Bone marrow or peripheral blood and serum samples collected during treatment on NCI-00-C-0070J are available
- PATIENT CHARACTERISTICS:
- See NCI-00-C-0070J
- PRIOR CONCURRENT THERAPY:
- See NCI-00-C-0070J
Exclusion
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2008
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT00899015
End Date
February 1 2008
Last Update
March 16 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.